7 results
P
adolescents, dual users (combustible- plus electronic- cigarettes users), electronic nicotine delivery systems (ENDS) users, never- or past- electronic nicotine delivery systems users
I/C
electronic nicotine delivery systems (ENDS), c-cigarettes, c-cig, dual users (combustible- plus electronic- cigarettes users) versus combustible-cigarettes users, electronic nicotine delivery systems (ENDS) users versus never- or past- electronic nicotine delivery systems users
O
proportion of complete or partial substitution of conventional to electronic cigarettes, odds ratio of quitting combustible cigarettes among electronic nicotine delivery systems users, prevalence of electronic cigarettes use, relationship between consumption and price increase of electronic and combustible cigarettes
P
livestock populations
I/C
vaccination alone, test-and-slaughter, vaccination in combination with test-and-slaughter, status-quo scenario
O
benefit-cost ratio (BCR), net present value, internal rate of return, payback period
P
healthy participants
I/C
mattress-based devices with piezoelectric sensors, actigraphy
O
better accuracy in distinguishing waking from sleeping epochs, data on sleep stages not available with actigraphy
P
breast cancer patients
I/C
one-stage implant reconstruction, two-stage implant reconstruction, with and without acellular dermal matrix (ADM)
O
patient satisfaction, aesthetic outcomes, complication rates, costs
P
patients with metastatic castration-sensitive prostate cancer
I/C
systemic treatments (docetaxel, abiraterone acetate, enzalutamide, apalutamide) added to androgen deprivation therapy (ADT), ADT alone
O
cost-effectiveness, quality-adjusted life-years (QALYs), incremental cost-effectiveness ratio (ICER)
P
straw, biochar, biogas, crop yield
I/C
straw recycling optimization model, traditional straw utilization model
O
lower greenhouse gas emissions, reduced electricity consumption, optimal ratios of straw for power generation, biogas and biochar production, and sale
P
patients with severe aortic valve stenosis at low surgical risk
I/C
transcatheter aortic valve implantation (TAVI), surgical aortic valve replacement (SAVR)
O
mortality, disabling stroke, symptom improvement, quality of life, cost-effectiveness, budget impact